News
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from November 10 to November 14, 2025
-
PRESS RELEASE
Nomad eSIM Announces Strong Growth with Expanded Enterprise and Consumer Offerings
Nomad eSIM, a business line of LotusFlare, reports over 100% global growth in consumer and enterprise segments, offering high-speed digital connectivity. Expansion includes unlimited data plans and API documentation for partner integration -
PRESS RELEASE
DigiKey to Highlight Innovative Automation Products and Industry-Leading Suppliers at SPS 2025
DigiKey showcases innovative automation products and top suppliers at SPS 2025, presenting a wide range of industrial automation solutions in Europe with interactive displays and expert insights -
-
-
PRESS RELEASE
Gold Terra is Upsizing Its Private Placement from C$6.3 Million to C$7.0 Million
Gold Terra Resource Corp. announces oversubscription of non-brokered private placement with strong investor demand, total gross proceeds of C$7,000,000 and issuance of 55 million common shares and flow-through common shares -
PRESS RELEASE
Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) with a BUY rating and USD 15.00 price target. Results show operational improvement and positive data on certepetide platform -
-